Patients with a CRP/ALB ratio > 20% had a longer duration of hospitalization and higher rates of poor kidney function, infection, and re-transplantation due to graft failure, as well as higher overall mortality, than those with a CRP/ALB ratio ≤ 20% (S1 Table). The gene discussed is ALB; the disease is infection.